Spy'ing on differentiation in neuroblastoma.
Spy'ing on differentiation in neuroblastoma. |
https://doi.org/10.18632/oncotarget.2325
Monika Podkowa,
and Meredith S. Irwin
|
5848-5849 |
NSCLC metastasis: going with ELMO3
NSCLC metastasis: going with ELMO3 |
https://doi.org/10.18632/oncotarget.2341
Marie-Anne Goyette,
and Jean-François Côté
|
5850-5851 |
Cannabinoids as therapeutic agents in cancer: current status and future implications
Cannabinoids as therapeutic agents in cancer: current status and future implications |
https://doi.org/10.18632/oncotarget.2233
Bandana Chakravarti,
Janani Ravi,
and Ramesh K. Ganju
|
5852-5872 |
The NF1 gene revisited – from bench to bedside
The NF1 gene revisited – from bench to bedside |
https://doi.org/10.18632/oncotarget.2194
Yoon-Sim Yap,
John R. McPherson,
Choon-Kiat Ong,
Steven G. Rozen,
Bin-Tean Teh,
Ann S. G. Lee,
and David F. Callen
|
5873-5892 |
Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus
Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus |
https://doi.org/10.18632/oncotarget.1839
Holger Schipper,
Vijay Alla,
Claudia Meier,
Dirk M. Nettelbeck,
Ottmar Herchenröder,
and Brigitte M. Pützer
|
5893-5907 |
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor |
https://doi.org/10.18632/oncotarget.1866
Koichi Azuma,
Akihiko Kawahara,
Kahori Sonoda,
Kazutaka Nakashima,
Kousuke Tashiro,
Kosuke Watari,
Hiroto Izumi,
Masayoshi Kage,
Michihiko Kuwano,
Mayumi Ono,
and Tomoaki Hoshino
|
5908-5919 |
SPHK1 regulates proliferation and survival responses in triple-negative breast cancer
SPHK1 regulates proliferation and survival responses in triple-negative breast cancer |
https://doi.org/10.18632/oncotarget.1874
Arpita Datta,
Ser Yue Loo,
Baohua Huang,
Lingkai Wong,
Sheryl S.L. Tan,
Tuan Zea Tan,
Soo-Chin Lee,
Jean Paul Thiery,
Yaw Chyn Lim,
Wei Peng Yong,
Yulin Lam,
Alan Prem Kumar,
and Celestial T. Yap
|
5920-5933 |
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer |
https://doi.org/10.18632/oncotarget.1904
Siti Norasikin Mohd Nafi,
Daniele Generali,
Gabriela Kramer-Marek,
Merel Gijsen,
Carla Strina,
Mariarosa Cappelletti,
Daniele Andreis,
Syed Haider,
Ji-Liang Li,
Esther Bridges,
Jacek Capala,
Roxanis Ioannis,
Adrian L. Harris,
and Anthony Kong
|
5934-5949 |
Anti-neoplastic properties of hydralazine in prostate cancer
Anti-neoplastic properties of hydralazine in prostate cancer |
https://doi.org/10.18632/oncotarget.1909
Inês Graça,
Elsa J. Sousa,
Pedro Costa-Pinheiro,
Filipa Q. Vieira,
Jorge Torres-Ferreira,
Maria Gabriela Martins,
Rui Henrique,
and Carmen Jerónimo
|
5950-5964 |
Identification of a gene expression driven progression pathway in myxoid liposarcoma
Identification of a gene expression driven progression pathway in myxoid liposarcoma |
https://doi.org/10.18632/oncotarget.2023
Loris De Cecco,
Tiziana Negri,
Silvia Brich,
Valentina Mauro,
Fabio Bozzi,
GianPaolo Dagrada,
Vittoria Disciglio,
Roberta Sanfilippo,
Alessandro Gronchi,
Maurizio D’Incalci,
Paolo G. Casali,
Silvana Canevari,
Marco A. Pierotti,
and Silvana Pilotti
|
5965-5977 |
A novel copper(I) complex induces ER-stress-mediated apoptosis and sensitizes B-acute lymphoblastic leukemia cells to chemotherapeutic agents
A novel copper(I) complex induces ER-stress-mediated apoptosis and sensitizes B-acute lymphoblastic leukemia cells to chemotherapeutic agents |
https://doi.org/10.18632/oncotarget.2027
Roberta Bortolozzi,
Giampietro Viola,
Elena Porcù,
Francesca Consolaro,
Cristina Marzano,
Maura Pellei,
Valentina Gandin,
and Giuseppe Basso
|
5978-5991 |
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase |
https://doi.org/10.18632/oncotarget.2042
Martina Olivero,
Daniela Dettori,
Sabrina Arena,
Davide Zecchin,
Erica Lantelme,
and Maria Flavia Di Renzo
|
5992-6002 |
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas |
https://doi.org/10.18632/oncotarget.2076
Enusha Karunasena,
Lauren J. McIver,
Brian R. Rood,
Xiaowei Wu,
Hongxiao Zhu,
Jasmin H. Bavarva,
and Harold R. Garner
|
6003-6014 |
Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail
Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail |
https://doi.org/10.18632/oncotarget.2109
Weijia Cai,
Qing Ye,
and Qing-Bai She
|
6015-6027 |
4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis
4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis |
https://doi.org/10.18632/oncotarget.2112
Tingfang Yi,
Eihab Kabha,
Evangelos Papadopoulos,
and Gerhard Wagner
|
6028-6037 |
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors |
https://doi.org/10.18632/oncotarget.2153
Maoyu Peng,
Rajyasree Emmadi,
Zebin Wang,
Elizabeth L. Wiley,
Peter H. Gann,
Seema A. Khan,
Nilanjana Banerji,
William McDonald,
Szilard Asztalos,
Thao N.D. Pham,
Debra A. Tonetti,
and Angela L. Tyner
|
6038-6048 |
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells |
https://doi.org/10.18632/oncotarget.2157
Yosuke Konno,
Peixin Dong,
Ying Xiong,
Fumihiko Suzuki,
Jiabin Lu,
Muyan Cai,
Hidemichi Watari,
Takashi Mitamura,
Masayoshi Hosaka,
Sharon J. B. Hanley,
Masataka Kudo,
and Noriaki Sakuragi
|
6049-6062 |
Dietary energy balance modulates ovarian cancer progression and metastasis
Dietary energy balance modulates ovarian cancer progression and metastasis |
https://doi.org/10.18632/oncotarget.2168
Zaid Al-Wahab,
Calvin Tebbe,
Jasdeep Chhina,
Sajad A. Dar,
Robert T. Morris,
Rouba Ali-Fehmi,
Shailendra Giri,
Adnan R. Munkarah,
and Ramandeep Rattan
|
6063-6075 |
Anti-apoptotic Effects of PCP4/PEP19 in Human Breast Cancer Cell Lines: A Novel Oncotarget
Anti-apoptotic Effects of PCP4/PEP19 in Human Breast Cancer Cell Lines: A Novel Oncotarget |
https://doi.org/10.18632/oncotarget.2161
Taiji Hamada,
Masakazu Souda,
Takuya Yoshimura,
Shoko Sasaguri,
Kazuhito Hatanaka,
Takashi Tasaki,
Takako Yoshioka,
Yasuyo Ohi,
Sohsuke Yamada,
Masato Tsutsui,
Yoshihisa Umekita,
and Akihide Tanimoto
|
6076-6086 |
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells |
https://doi.org/10.18632/oncotarget.2173
Yue-Zhi Lee,
Cheng-Wei Yang,
Hsin-Yu Chang,
Hsing-Yu Hsu,
Ih-Shen Chen,
Hsun-Shuo Chang,
Chih-Hao Lee,
Jinq-chyi Lee,
Chidambaram Ramesh Kumar,
Ya-Qi Qiu,
Yu-Sheng Chao,
and Shiow-Ju Lee
|
6087-6101 |
Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer
Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer |
https://doi.org/10.18632/oncotarget.2174
Janet Mendonca,
Anup Sharma,
Hae-Soo Kim,
Hans Hammers,
Alan Meeker,
Angelo De Marzo,
Michael Carducci,
Michael Kauffman,
Sharon Shacham,
and Sushant Kachhap
|
6102-6112 |
Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling
Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling |
https://doi.org/10.18632/oncotarget.2176
Rui Wang,
Dong-Qin Chen,
Jia-Yuan Huang,
Kai Zhang,
Bing Feng,
Ban-Zhou Pan,
Jing Chen,
Wei De,
and Long-Bang Chen
|
6113-6129 |
Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice
Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice |
https://doi.org/10.18632/oncotarget.2177
Namit Sharma,
Stephanie Everingham,
Li-Fan Zeng,
Zhong-Yin Zhang,
Reuben Kapur,
and Andrew W.B. Craig
|
6130-6141 |
AKT regulates NPM dependent ARF localization and p53mut stability in tumors
AKT regulates NPM dependent ARF localization and p53mut stability in tumors |
https://doi.org/10.18632/oncotarget.2178
Garth Hamilton,
Aswin G. Abraham,
Jennifer Morton,
Oliver Sampson,
Dafni E. Pefani,
Svetlana Khoronenkova,
Anna Grawenda,
Angelos Papaspyropoulos,
Nigel Jamieson,
Colin McKay,
Owen Sansom,
Grigory L. Dianov,
and Eric O’Neill
|
6142-6167 |
Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites
Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites |
https://doi.org/10.18632/oncotarget.2179
Junfeng Jiang,
Peilin Jia,
Bairong Shen,
and Zhongming Zhao
|
6168-6177 |
F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a
F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a |
https://doi.org/10.18632/oncotarget.2183
Xinchao Zhang,
Ye Kong,
Xia Xu,
Huaixin Xing,
Yingjie Zhang,
Fengjuan Han,
Wenjuan Li,
Qing Yang,
Jiping Zeng,
Jihui Jia,
and Zhifang Liu
|
6178-6190 |
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome |
https://doi.org/10.18632/oncotarget.2186
Erika Ortolan,
Alice Giacomino,
Francesca Martinetto,
Simona Morone,
Nicola Lo Buono,
Enza Ferrero,
Giorgio Scagliotti,
Silvia Novello,
Sara Orecchia,
Enrico Ruffini,
Ida Rapa,
Luisella Righi,
Marco Volante,
and Ada Funaro
|
6191-6205 |
Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer
Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer |
https://doi.org/10.18632/oncotarget.2187
Cristina Bilbao-Sieyro,
Raquel Ramírez-Moreno,
Germán Rodríguez-González,
Orlando Falcón,
Laureano León,
Santiago Torres,
Leandro Fernández,
Sergio Alonso,
Nicolás Díaz-Chico,
Manuel Perucho,
and Juan Carlos Díaz-Chico
|
6206-6217 |
MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R
MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R |
https://doi.org/10.18632/oncotarget.2189
Yi-Yuan Ge,
Qing Shi,
Zhi-Yuan Zheng,
Jiao Gong,
Chunxian Zeng,
Jine Yang,
and Shi-Mei Zhuang
|
6218-6228 |
The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy
The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy |
https://doi.org/10.18632/oncotarget.2190
Italia Anna Asteriti,
Erica Di Cesare,
Fabiola De Mattia,
Volker Hilsenstein,
Beate Neumann,
Enrico Cundari,
Patrizia Lavia,
and Giulia Guarguaglini
|
6229-6242 |
SHP-1 is a target of regorafenib in colorectal cancer
SHP-1 is a target of regorafenib in colorectal cancer |
https://doi.org/10.18632/oncotarget.2191
Li-Ching Fan,
Hao-Wei Teng,
Chung-Wai Shiau,
Hang Lin,
Man-Hsin Hung,
Yen-Lin Chen,
Jui-Wen Huang,
Wei-Tien Tai,
Hui-Chuan Yu,
and Kuen-Feng Chen
|
6243-6251 |
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells |
https://doi.org/10.18632/oncotarget.2193
Mohamed-Amine Hamouda,
Nathalie Belhacene,
Alexandre Puissant,
Pascal Colosetti,
Guillaume Robert,
Arnaud Jacquel,
Bernard Mari,
Patrick Auberger,
and Frederic Luciano
|
6252-6266 |
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling |
https://doi.org/10.18632/oncotarget.2195
Ilenia Segatto,
Stefania Berton,
Maura Sonego,
Samuele Massarut,
Tiziana Perin,
Erica Piccoli,
Alfonso Colombatti,
Andrea Vecchione,
Gustavo Baldassarre,
and Barbara Belletti
|
6267-6279 |
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin |
https://doi.org/10.18632/oncotarget.2196
Juliette Lambert,
Jérôme Lambert,
Olivier Nibourel,
Cécile Pautas,
Sandrine Hayette,
Jean-Michel Cayuela,
Christine Terré,
Philippe Rousselot,
Hervé Dombret,
Sylvie Chevret,
Claude Preudhomme,
Sylvie Castaigne,
and Aline Renneville
|
6280-6288 |
Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2α via AKT in prostate cancer cells
Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2α via AKT in prostate cancer cells |
https://doi.org/10.18632/oncotarget.2198
Soma Vignarajan,
Chanlu Xie,
Mu Yao,
Yuting Sun,
Ulla Simanainen,
Paul Sved,
Tao Liu,
and Qihan Dong
|
6289-6299 |
Cdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition (EMT) in zebrafish
Cdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition (EMT) in zebrafish |
https://doi.org/10.18632/oncotarget.2204
Ching-Hung Chen,
Dar-Shong Lin,
Chieh-Wen Cheng,
Chun-Ju Lin,
Yu-Kang Lo,
Chueh-Chuan Yen,
Alan Yueh-Luen Lee,
and Chung-Der Hsiao
|
6300-6311 |
Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells
Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells |
https://doi.org/10.18632/oncotarget.2205
Keren Cohen,
Nir Flint,
Shachar Shalev,
Daniel Erez,
Tal Baharal,
Paul J. Davis,
Aleck Hercbergs,
Martin Ellis,
and Osnat Ashur-Fabian
|
6312-6322 |
Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma
Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma |
https://doi.org/10.18632/oncotarget.2210
Wen-Pin Su,
Sen-Huei Hsu,
Cheng-Kuei Wu,
Song-Bin Chang,
Yi-Ju Lin,
Wen-Bin Yang,
Jan-Jong Hung,
Wen-Tai Chiu,
Shun-Fen Tzeng,
Yau-Lin Tseng,
Jang-Yang Chang,
Wu-Chou Su,
and Hungjiun Liaw
|
6323-6337 |
Impact of human MLL/COMPASS and polycomb complexes on the DNA methylome
Impact of human MLL/COMPASS and polycomb complexes on the DNA methylome |
https://doi.org/10.18632/oncotarget.2215
Emily L. Putiri,
Rochelle L. Tiedemann,
Chunsheng Liu,
Jeong-Hyeon Choi,
and Keith D. Robertson
|
6338-6352 |
Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy
Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy |
https://doi.org/10.18632/oncotarget.2216
Jianying Guo,
Satoru Shinriki,
Yu Su,
Takuya Nakamura,
Mitsuhiro Hayashi,
Yukimoto Tsuda,
Yoshitaka Murakami,
Masayoshi Tasaki,
Takuichiro Hide,
Tatsuya Takezaki,
Jun-ichi Kuratsu,
Satoshi Yamashita,
Mitsuharu Ueda,
Jian-Dong Li,
Yukio Ando,
and Hirofumi Jono
|
6353-6364 |
Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells |
https://doi.org/10.18632/oncotarget.2219
Gang Meng,
Mao Xia,
Diancheng Wang,
Aiping Chen,
Yongshan Wang,
Hongwei Wang,
Decai Yu,
and Jiwu Wei
|
6365-6374 |
MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer
MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer |
https://doi.org/10.18632/oncotarget.2221
Ross M. Drayton,
Stefan Peter,
Katie Myers,
Saiful Miah,
Ewa Dudziec,
Helen E. Bryant,
and James W. F. Catto
|
6375-6386 |
Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway
Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway |
https://doi.org/10.18632/oncotarget.2201
Qingling Li,
Jie Li,
Ting Wen,
Weiqi Zeng,
Cong Peng,
Siyu Yan,
Jieqiong Tan,
Keda Yang,
Shuang Liu,
Aiyuan Guo,
Chong Zhang,
Juan Su,
Minghao Jiang,
Zhaoqian Liu,
Honghao Zhou,
and Xiang Chen
|
6387-6403 |
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm |
https://doi.org/10.18632/oncotarget.2223
Albrecht Stenzinger,
Volker Endris,
Nicole Pfarr,
Mindaugas Andrulis,
Korinna Jöhrens,
Frederick Klauschen,
Udo Siebolts,
Thomas Wolf,
Philipp-Sebastian Koch,
Miriam Schulz,
Wolfgang Hartschuh,
Sergij Goerdt,
Jochen K. Lennerz,
Claudia Wickenhauser,
Wolfram Klapper,
Ioannis Anagnostopoulos,
and Wilko Weichert
|
6404-6413 |
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents |
https://doi.org/10.18632/oncotarget.2225
Abhijit A. Patil,
Parag Sayal,
Marie-Lise Depondt,
Ryan D. Beveridge,
Anthony Roylance,
Deepti H. Kriplani,
Katie N. Myers,
Angela Cox,
David Jellinek,
Malee Fernando,
Thomas A. Carroll,
and Spencer J. Collis
|
6414-6424 |
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth |
https://doi.org/10.18632/oncotarget.2228
Yuh-Shyan Tsai,
Chen-Li Lai Lai,
Chih-Ho Lai,
Kai-Hsiung Chang,
Kaijie Wu,
Shu-Fen Tseng,
Ladan Fazli,
Martin Gleave,
Guanghua Xiao,
Leah Gandee,
Nima Sharifi,
Loredana Moro,
Tzong-Shin Tzai,
and Jer-Tsong Hsieh
|
6425-6436 |
A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer
A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer |
https://doi.org/10.18632/oncotarget.2237
Mireia Berdiel-Acer,
Antoni Berenguer,
Rebeca Sanz-Pamplona,
Daniel Cuadras,
Xavier Sanjuan,
Maria José Paules,
Cristina Santos,
Ramon Salazar,
Victor Moreno,
Gabriel Capella,
Alberto Villanueva,
and David G. Molleví
|
6437-6452 |
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles |
https://doi.org/10.18632/oncotarget.2203
Xunhao Xiong,
Rochelle R. Arvizo,
Sounik Saha,
David J. Robertson,
Scott McMeekin,
Resham Bhattacharya,
and Priyabrata Mukherjee
|
6453-6465 |
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell |
https://doi.org/10.18632/oncotarget.2238
Claudia C. Roskopf,
Christian B. Schiller,
Todd A. Braciak,
Sebastian Kobold,
Ingo A. Schubert,
Georg H. Fey,
Karl-Peter Hopfner,
and Fuat S. Oduncu
|
6466-6483 |
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells |
https://doi.org/10.18632/oncotarget.2248
G. Kenneth Gray,
Braden C. McFarland,
Amber L. Rowse,
Sara A. Gibson,
and Etty N. Benveniste
|
6484-6496 |
Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells
Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells |
https://doi.org/10.18632/oncotarget.2267
Xue-Tao Li,
Rui-Jun Ju,
Xiu-Ying Li,
Fan Zeng,
Ji-Feng Shi,
Lei Liu,
Cheng-Xiang Zhang,
Meng-Ge Sun,
Jin-Ning Lou,
and Wan-Liang Lu
|
6497-6511 |
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer |
https://doi.org/10.18632/oncotarget.2270
Jorge Franco,
Agnieszka . K. Witkiewicz,
and Erik S. Knudsen
|
6512-6525 |
Treatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell death
Treatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell death |
https://doi.org/10.18632/oncotarget.2310
Zhe Yu,
Jie Geng,
Minghua Zhang,
Yong Zhou,
Qingyu Fan,
and Jingyuan Chen
|
6526-6539 |
The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways
The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways |
https://doi.org/10.18632/oncotarget.2119
Boh-Ram Kim,
Kyungsil Yoon,
Hyun-Jung Byun,
Seung Hee Seo,
Seung-Hoon Lee,
and Seung Bae Rho
|
6540-6551 |